لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Pardee TS, Hagag N, Singh B, Zamkoff KW, Locher E, Stevens M, Gladstone DE

المصدر: Journal of Applied Research; 2006, Vol. 6 Issue 3, p196-200, 5p

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Ravandi F; Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA., Subklewe M; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Laboratory for Translational Research, Gene Center, LMU Munich, Munich, Germany., Walter RB; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Vachhani P; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Ossenkoppele G; Amsterdam University Medical Center, Amsterdam, The Netherlands., Buecklein V; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Laboratory for Translational Research, Gene Center, LMU Munich, Munich, Germany., Döhner H; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Jongen-Lavrencic M; Department of Hematology, Erasmus University Medical Center Cancer Institute, Rotterdam, The Netherlands., Baldus CD; Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany., Fransecky L; Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany., Pardee TS; Department of Internal Medicine, Section on Hematology and Oncology, Atrium Health Wake Forest Baptist, Winston-Salem, NC, USA., Kantarjian H; Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA., Yen PK; Amgen Inc, Thousand Oaks, CA, USA., Mukundan L; Amgen Inc, South San Francisco, CA, USA., Panwar B; Amgen Inc, South San Francisco, CA, USA., Yago MR; Amgen Inc, South San Francisco, CA, USA., Agarwal S; Amgen Inc, Thousand Oaks, CA, USA., Khaldoyanidi SK; Amgen Inc, Thousand Oaks, CA, USA., Stein A; Gehr Family Center for Leukemia Research, City of Hope National Medical Center, Duarte, CA, USA.

المصدر: Leukemia & lymphoma [Leuk Lymphoma] 2024 Sep; Vol. 65 (9), pp. 1281-1291. Date of Electronic Publication: 2024 May 07.

نوع المنشور: Journal Article; Clinical Trial, Phase I; Multicenter Study

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/pathology , Leukemia, Myeloid, Acute*/diagnosis , Antibodies, Bispecific*/administration & dosage , Antibodies, Bispecific*/adverse effects , Antibodies, Bispecific*/therapeutic use, Humans ; Male ; Female ; Middle Aged ; Adult ; Aged ; Treatment Outcome ; Young Adult ; Maximum Tolerated Dose ; Drug Resistance, Neoplasm/drug effects ; Sialic Acid Binding Ig-like Lectin 3/metabolism ; Recurrence ; Aged, 80 and over ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/pathology ; Dose-Response Relationship, Drug ; Cytokine Release Syndrome/etiology

المؤلفون: Cheng JJ; Wake Forest University School of Medicine, Department of Medicine, United States of America. Electronic address: justincheng@mednet.ucla.edu., Tooze JA; Wake Forest University School of Medicine, Division of Public Health Sciences, Department of Biostatistics and Data Science, United States of America., Callahan KE; Wake Forest University School of Medicine, Department of Medicine, Section of Gerontology and Geriatric Medicine, United States of America., Pajewski NM; Wake Forest University School of Medicine, Division of Public Health Sciences, Department of Biostatistics and Data Science, United States of America., Pardee TS; Wake Forest University School of Medicine, Department of Medicine, Section of Hematology and Oncology, Wake Forest University School of Medicine, 1 Medical Center Blvd., Winston-Salem, NC 27157, United States of America., Reed DR; Wake Forest University School of Medicine, Department of Medicine, Section of Hematology and Oncology, Wake Forest University School of Medicine, 1 Medical Center Blvd., Winston-Salem, NC 27157, United States of America., Klepin HD; Wake Forest University School of Medicine, Department of Medicine, Section of Hematology and Oncology, Wake Forest University School of Medicine, 1 Medical Center Blvd., Winston-Salem, NC 27157, United States of America.

المصدر: Journal of geriatric oncology [J Geriatr Oncol] 2023 Sep; Vol. 14 (7), pp. 101509. Date of Electronic Publication: 2023 Jul 14.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101534770 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-4076 (Electronic) Linking ISSN: 18794068 NLM ISO Abbreviation: J Geriatr Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Frailty*/epidemiology , Frailty*/diagnosis , Leukemia, Myeloid, Acute*/drug therapy, Humans ; Male ; Aged ; United States ; Female ; Retrospective Studies ; Electronic Health Records ; Medicare ; Primary Health Care

المؤلفون: Reed DR; Section On Hematology and Medical Oncology, Wake Forest University School of Medicine, Wake Forest Baptist Health Comprehensive Cancer Center, Medical Center Boulevard, Winston-Salem, NC, 27012, USA. drreed@wakehealth.edu., Wooster M; Section On Hematology and Medical Oncology, Wake Forest University School of Medicine, Wake Forest Baptist Health Comprehensive Cancer Center, Medical Center Boulevard, Winston-Salem, NC, 27012, USA., Isom S; Section On Hematology and Medical Oncology, Wake Forest University School of Medicine, Wake Forest Baptist Health Comprehensive Cancer Center, Medical Center Boulevard, Winston-Salem, NC, 27012, USA., Ellis LR; Section On Hematology and Medical Oncology, Wake Forest University School of Medicine, Wake Forest Baptist Health Comprehensive Cancer Center, Medical Center Boulevard, Winston-Salem, NC, 27012, USA., Howard DS; Section On Hematology and Medical Oncology, Wake Forest University School of Medicine, Wake Forest Baptist Health Comprehensive Cancer Center, Medical Center Boulevard, Winston-Salem, NC, 27012, USA., Manuel M; Section On Hematology and Medical Oncology, Wake Forest University School of Medicine, Wake Forest Baptist Health Comprehensive Cancer Center, Medical Center Boulevard, Winston-Salem, NC, 27012, USA., Dralle S; Section On Hematology and Medical Oncology, Wake Forest University School of Medicine, Wake Forest Baptist Health Comprehensive Cancer Center, Medical Center Boulevard, Winston-Salem, NC, 27012, USA., Lyerly S; Section On Hematology and Medical Oncology, Wake Forest University School of Medicine, Wake Forest Baptist Health Comprehensive Cancer Center, Medical Center Boulevard, Winston-Salem, NC, 27012, USA., Bhave R; Section On Hematology and Medical Oncology, Wake Forest University School of Medicine, Wake Forest Baptist Health Comprehensive Cancer Center, Medical Center Boulevard, Winston-Salem, NC, 27012, USA., Powell BL; Section On Hematology and Medical Oncology, Wake Forest University School of Medicine, Wake Forest Baptist Health Comprehensive Cancer Center, Medical Center Boulevard, Winston-Salem, NC, 27012, USA., Pardee TS; Section On Hematology and Medical Oncology, Wake Forest University School of Medicine, Wake Forest Baptist Health Comprehensive Cancer Center, Medical Center Boulevard, Winston-Salem, NC, 27012, USA.

المصدر: Annals of hematology [Ann Hematol] 2023 Apr; Vol. 102 (4), pp. 897-906. Date of Electronic Publication: 2023 Mar 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy, Humans ; Adult ; Child, Preschool ; Infant ; Middle Aged ; Treatment Outcome ; Remission Induction ; Alemtuzumab/therapeutic use

المؤلفون: Anderson R; Section on Hematology and Oncology, Comprehensive Cancer Center of Wake Forest Baptist Health, Medical Center Boulevard, Winston-Salem, NC 27157, USA., Pladna KM; Section on Hematology and Oncology, Comprehensive Cancer Center of Wake Forest Baptist Health, Medical Center Boulevard, Winston-Salem, NC 27157, USA., Schramm NJ; Section on Hematology and Oncology, Comprehensive Cancer Center of Wake Forest Baptist Health, Medical Center Boulevard, Winston-Salem, NC 27157, USA., Wheeler FB; Department of Cancer Biology, Comprehensive Cancer Center of Wake Forest Baptist Health, Winston-Salem, NC 27157, USA., Kridel S; Department of Cancer Biology, Comprehensive Cancer Center of Wake Forest Baptist Health, Winston-Salem, NC 27157, USA., Pardee TS; Section on Hematology and Oncology, Comprehensive Cancer Center of Wake Forest Baptist Health, Medical Center Boulevard, Winston-Salem, NC 27157, USA.; Department of Cancer Biology, Comprehensive Cancer Center of Wake Forest Baptist Health, Winston-Salem, NC 27157, USA.; Cornerstone Pharmaceuticals Inc., Cranbury, NJ 08512, USA.

المصدر: Cancers [Cancers (Basel)] 2023 Jan 12; Vol. 15 (2). Date of Electronic Publication: 2023 Jan 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

المؤلفون: Lin KH; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Rutter JC; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Xie A; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Killarney ST; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Vaganay C; Université de Paris, Génomes, Biologie Cellulaire et Thérapeutique U944, INSERM, CNRS, Paris, France., Benaksas C; Université de Paris, Génomes, Biologie Cellulaire et Thérapeutique U944, INSERM, CNRS, Paris, France., Ling F; Université de Paris, Génomes, Biologie Cellulaire et Thérapeutique U944, INSERM, CNRS, Paris, France., Sodaro G; Université de Paris, Génomes, Biologie Cellulaire et Thérapeutique U944, INSERM, CNRS, Paris, France., Meslin PA; Université de Paris, Génomes, Biologie Cellulaire et Thérapeutique U944, INSERM, CNRS, Paris, France., Bassil CF; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Fenouille N; Université de Paris, Génomes, Biologie Cellulaire et Thérapeutique U944, INSERM, CNRS, Paris, France., Hoj J; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Washart R; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Ang HX; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Cerda-Smith C; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Chaintreuil P; Université Côte d'Azur, Nice, France., Jacquel A; Université Côte d'Azur, Nice, France., Auberger P; Université Côte d'Azur, Nice, France., Forget A; Université de Paris, Génomes, Biologie Cellulaire et Thérapeutique U944, INSERM, CNRS, Paris, France., Itzykson R; Université de Paris, Génomes, Biologie Cellulaire et Thérapeutique U944, INSERM, CNRS, Paris, France., Lu M; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Lin J; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA., Pierobon M; Center for Applied Proteomics and Molecular Medicine, School of Systems Biology, George Mason University, Manassas, VA, USA., Sheng Z; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA., Li X; Department of Biomedical Engineering, Duke University, Durham, NC, USA., Chilkoti A; Department of Biomedical Engineering, Duke University, Durham, NC, USA., Owzar K; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA., Rizzieri DA; Department of Medicine, Duke University Medical Center, Durham, NC, USA., Pardee TS; Department of Internal Medicine, Section on Hematology and Oncology, Wake Forest Baptist Health, Winston-Salem, NC, USA., Benajiba L; Université de Paris, Génomes, Biologie Cellulaire et Thérapeutique U944, INSERM, CNRS, Paris, France., Petricoin E; Center for Applied Proteomics and Molecular Medicine, School of Systems Biology, George Mason University, Manassas, VA, USA., Puissant A; Université de Paris, Génomes, Biologie Cellulaire et Thérapeutique U944, INSERM, CNRS, Paris, France. alexandre.puissant@inserm.fr., Wood KC; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA. kris.wood@duke.edu.

المصدر: Nature cancer [Nat Cancer] 2022 Jul; Vol. 3 (7), pp. 837-851. Date of Electronic Publication: 2022 Jun 06.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/drug therapy , Proto-Oncogene Proteins c-akt*/metabolism, Animals ; Antineoplastic Combined Chemotherapy Protocols ; Karyopherins/antagonists & inhibitors ; Mice ; Receptors, Cytoplasmic and Nuclear/antagonists & inhibitors ; Receptors, Cytoplasmic and Nuclear/metabolism ; Receptors, Purinergic P2Y2/metabolism ; United States ; Exportin 1 Protein